MedPath

VOLIBRIS

VOLIBRIS

Approved
DIN Number

02307073

Drug Class

Human

Market Date

Jun 24, 2008

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02307073
AIG Number0152452002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02KX02 AMBRISENTAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:48.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AMBRISENTANActive
Strength: 10 MG
Monograph: AMBRISENTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.